2m 2m 2m 2m 2m 2m 2m
- $41.7MMarket Cap
- -43.00%1-Year Change
- ChemicalsIndustry
Biolargo (BLGO)
Key Performance
More- Earnings Score: N/A
- Momentum Score: 25
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
Gabelli Funds to Host 3rd Annual PFAS Symposium at The Harvard Club, New York, NY
Gabelli Funds will host a symposium exploring PFAS (Per- and Polyfluoroalkyl Substances), bringing together experts to discuss environmental and public health challenges related to these persistent 'forever chemicals'.
08/28/2025, 8:00 AM • GlobeNewswire
Peers
Statistics
MoreInformation as of 06/03/2026
Company Profile
BioLargo, Inc. invents, develops, and commercializes various platform technologies in the United States. The company's technologies solve challenging environmental problems comprising per- and polyfluoroalkyl substances (PFAS) water contamination; advanced water and wastewater treatment; industrial odor and volatile organic compounds control, air quality control, and infection control; and myriad environmental remediation. It provides full-service environmental engineering, battery energy storage, and advanced antimicrobial medical device platforms. BioLargo, Inc. is based in Westminster, California.
Key Executives
- Dennis Calvert
- Kenneth Reay Code
- Joseph L. Provenzano
- Steven V. Harrison
- Richard Smith
Current Ownership Distribution
- Other233.1M (72.64%)
- Insiders86.0M (26.81%)
- Institutions1.8M (0.55%)
- Mutual Funds0 (0.00%)